GPER, which is highly expressed in aberrant endometrial cancer cells, has a similar expression trend to that of ERα, indicating that estrogen may activate intracellular GPER regulation via an intracellular pathway, which further increases the incidence of abnormal cell proliferation (Bulun et al., 2004). This evidence concerns the gene GPER1 and endometrial cancer.